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Improving the evidence base for social prescribing
Kate E Hamilton-West reader in health psychology, faculty director of medical social sciences, Erica
Gadsby senior research fellow, Sarah Hotham research fellow
Centre for Health Services Studies, University of Kent, Canterbury CT2 7NF, UK
Salisbury’s article raises important points about the widespread
rollout of social prescribing.1 Linking people with services that
could help tackle problems that contribute to reduced wellbeing
seems sensible, but the approach rests on several problematic
assumptions.
A recent systematic review2 concluded that current evidence on
social prescribing is insufficient to judge either success or value
for money. Of the 15 evaluations identified, most were small
scale and limited by poor design and reporting. Studies on
patient and referrer experience mainly reported positive findings
but showed limited understanding or familiarity with social
prescribing.
We used evaluability assessment to examine social prescribing
programmes and reported on the lessons we learnt.3 These
included ensuring that programmes are designed with
stakeholder involvement and buy in; that information
governance and data sharing agreements are in place from the
start; that staffing levels are sufficient to cover the range of
activities involved in service delivery and monitoring; that social
prescribing programmes are co-located with primary care; and
that linkage to health service data systems is established as part
of the programme design.
NHS England is working to improve the evidence base for social
prescribing, including funding 23 projects through the health
and wellbeing fund to find out which models work best4 and
developing resources to support the implementation and
evaluation of social prescribing programmes.5 Gaps in the
evidence base could also be filled by planning programmes
more systematically, with evaluation frameworks developed
through collaboration between those involved in developing,
delivering, participating in and evaluating the programmes.
To realise the potential benefits of social prescribing for patients,
general practitioners, and the NHS,6 the underlying assumptions
must be made explicit, and research efforts should be targeted
towards these. We have proposed a list of assumptions7 as the
starting point for taking this work forward.
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